Merck
Worldwide
   
En español

 


About this Study
Condition Intervention Phase
Human Immunodeficiency Virus Drug: MK-0518 Phase III
BENCHMRK-IT
More about
 
You may be eligible for the study if you are:
  • HIV positive with viral load greater than 5000.
  • Naïve to antiretroviral therapy.
  • 18 years of age or older.
Participation in this 2-year study includes at no cost:
  • Regular doctor visits
  • Investigational study drug or placebo
  • Laboratory testing

Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.
Contact Merck Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA)